Impact BioMedical, INC. Basic Shares Outstanding (Weighted Average)
Impact BioMedical, INC. (IBO) reported Basic Shares Outstanding (Weighted Average) of 107.82 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- Impact BioMedical, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 107.82M shares, a 784.84% increase year-over-year.
- Impact BioMedical, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 107.79M shares, a 793.54% increase year-over-year.
- Impact BioMedical, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 89.77M shares, a 679.94% increase year-over-year.
- Impact BioMedical, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 12.19M shares, a 5.92% increase year-over-year.
- Impact BioMedical, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 31.55M shares, a 193.30% increase from fiscal 2024.
- Impact BioMedical, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 10.76M shares, a 82.15% decline from fiscal 2023.
- Impact BioMedical, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 60.25M shares, a 14.54% decline from fiscal 2022.
- Impact BioMedical, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 70.50M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 107.82M shares 10-Q · filed 2026-08-07 | 107.80M shares 10-Q · filed 2026-08-07 | 101.79M shares derived: average of 3 quarters · filed 2026-08-07 | 79.39M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | 107.79M shares 10-Q · filed 2026-05-12 | 98.78M shares derived: average of 2 quarters · filed 2026-05-12 | 69.91M shares derived: average of 3 quarters · filed 2026-05-12 | 55.48M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | 89.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 50.98M shares derived: average of 2 quarters · filed 2026-03-11 | 38.05M shares derived: average of 3 quarters · filed 2026-08-07 | 31.55M shares 10-K · filed 2026-03-11 | ||
| 2025-09-30 | 12.19M shares 10-Q · filed 2025-11-07 | 12.19M shares derived: average of 2 quarters · filed 2026-08-07 | 12.14M shares 10-Q · filed 2025-11-07 | 11.99M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | 12.19M shares 10-Q · filed 2026-08-07 | 12.12M shares 10-Q · filed 2026-08-07 | 11.92M shares derived: average of 3 quarters · filed 2026-08-07 | 11.82M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | 12.06M shares 10-Q · filed 2026-05-12 | 11.79M shares derived: average of 2 quarters · filed 2026-05-12 | 11.69M shares derived: average of 3 quarters · filed 2026-05-12 | 11.27M shares derived: average of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | 11.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 11.51M shares derived: average of 2 quarters · filed 2026-03-11 | 11.00M shares derived: average of 3 quarters · filed 2026-03-11 | 10.76M shares 10-K · filed 2026-03-11 | ||
| 2024-09-30 | 11.50M shares 10-Q · filed 2025-11-07 | 10.75M shares derived: average of 2 quarters · filed 2025-11-07 | 10.51M shares 10-Q · filed 2025-11-07 | 15.25M shares derived: average of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | 10.00M shares 10-Q · filed 2025-08-14 | 10.00M shares 10-Q · filed 2024-08-13 | 10.00M shares 10-Q · filed 2025-08-14 | 16.50M shares derived: average of 3 quarters · filed 2025-08-14 | 30.00M shares derived: average of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | 10.00M shares 10-Q · filed 2025-05-14 | 19.75M shares derived: average of 2 quarters · filed 2025-05-14 | 36.67M shares derived: average of 3 quarters · filed 2025-05-14 | 45.12M shares derived: average of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | 29.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 50.00M shares derived: average of 2 quarters · filed 2025-03-28 | 56.83M shares derived: average of 3 quarters · filed 2025-03-28 | 60.25M shares 10-K · filed 2025-03-28 | ||
| 2023-09-30 | 70.50M shares 10-Q · filed 2024-11-12 | 70.50M shares derived: average of 2 quarters · filed 2024-11-12 | 70.50M shares 10-Q · filed 2024-11-12 | 70.50M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 70.50M shares 10-Q · filed 2024-08-13 | 3.88B shares 10-Q · filed 2023-10-05 | 70.50M shares 10-Q · filed 2024-08-13 | 3.88B shares 10-Q · filed 2023-10-05 | 70.50M shares derived: average of 3 quarters · filed 2024-08-13 | 70.50M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 70.50M shares 10-Q · filed 2024-05-10 | 70.50M shares derived: average of 2 quarters · filed 2024-05-10 | 70.50M shares derived: average of 3 quarters · filed 2024-05-10 | 1.02B shares derived: average of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | 70.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | 70.50M shares derived: average of 2 quarters · filed 2024-02-20 | 1.34B shares derived: average of 3 quarters · filed 2024-02-20 | 70.50M shares 10-K · filed 2024-02-20 | ||
| 2022-09-30 | 70.50M shares 10-Q · filed 2023-11-13 | 1.97B shares derived: average of 2 quarters · filed 2023-11-13 | 70.50M shares 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | 3.88B shares 10-Q · filed 2023-10-05 | 3.88B shares 10-Q · filed 2023-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |